Intravenous N-acetylcysteine plus high-dose hydration versus high-dose hydration and standard hydration for the prevention of contrast-induced nephropathy: CASIS-A multicenter prospective controlled trial

International Journal of Cardiology

Volumn 155, Issue 3, 2012, Pages 418-423

  Koc, Fatih ^a   Ozdemir, Kurtulus ^b   Kaya, Mehmet Gungor ^c   Dogdu, Orhan ^c   Vatankulu, Mehmet Akif ^b   Ayhan, Selim ^b   Erkorkmaz, Unal ^a   Sonmez, Osman ^b   Aygul, Meryem Ulku ^b   Kalay, Nihat ^c   Kayrak, Mehmet ^b   Karabag, Turgut ^b   Alihanoglu, Yusuf ^b   Gunebakmaz, Ozgur ^c  

^a GAZIOSMANPASA UNIVERSITY   (Turkey)

^b SELCUK UNIVERSITY   (Turkey)

^c ERCIYES UNIVERSITY   (Turkey)

Author keywords

Contrast induced nephropathy; High dose hydration; Intravenous N acetylcysteine

Indexed keywords

ACETYLCYSTEINE; CREATININE; SODIUM CHLORIDE;

ADULT; AGED; ANGIOCARDIOGRAPHY; ARTICLE; CONTRAST INDUCED NEPHROPATHY; CONTROLLED STUDY; CREATININE BLOOD LEVEL; CREATININE CLEARANCE; DISEASE COURSE; DOSE RESPONSE; DRUG EFFICACY; FEMALE; FLUID THERAPY; HUMAN; HYDRATION; KIDNEY DYSFUNCTION; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

ACETYLCYSTEINE; AGED; ANGIOPLASTY, BALLOON, CORONARY; CONTRAST MEDIA; CORONARY ANGIOGRAPHY; CORONARY DISEASE; CREATININE; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FLUID THERAPY; FOLLOW-UP STUDIES; FREE RADICAL SCAVENGERS; HUMANS; INFUSIONS, INTRAVENOUS; KIDNEY DISEASES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TREATMENT OUTCOME;

EID: 84857787258     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.041     Document Type: Article

References (40)

1. G. Marenzi, E. Assanelli, and I. Marana N-acetylcysteine and contrast-induced nephropathy in primary angioplasty N Engl J Med 354 2006 2773 2782 (Pubitemid 43974195)
2. B.J. Barrett, and P.S. Parfrey Clinical practice. Preventing nephropathy induced by contrast medium N Engl J Med 354 2006 379 386 (Pubitemid 43145062)
3. M. Tepel, M. van der Giet, C. Schwarzfeld, and U. Laufer Prevention of radiographic-contrast-agent-induced reductions in renal function by acetylcysteine N Engl J Med 343 2000 180 184 (Pubitemid 30489215)
4. S.H. Jo, B.K. Koo, and J.S. Park Prevention of radiocontrast medium-induced nephropathy using short-term high-dose simvastatin in patients with renal insufficiency undergoing coronary angiography (PROMISS) trial-a randomized controlled study Am Heart J 155 2008 499.e1 499.e8
5. C. Briguori, F. Airoldi, and D. D'Andrea Renal Insufficiency Following Contrast Media Administration Trial (REMEDIAL): a randomized comparison of 3 preventive strategies Circulation 115 2007 1211 1277
6. L.J. Diaz-Sandoval, B.D. Kosowsky, and D.W. Losordo Acetylcysteine to prevent angiography-related renal tissue injury (the APART trial) Am J Cardiol 89 2002 356 358 (Pubitemid 34113804)
7. K.G. Shyu, J.J. Cheng, and P. Kuan Acetylcysteine protects against acute renal damage in patients with abnormal renal function undergoing a coronary procedure J Am Coll Cardiol 40 2002 1383 1388 (Pubitemid 35192860)
8. C. Briguori, A. Colombo, and A. Violante Standard vs double dose of N-acetylcysteine to prevent contrast agent-associated nephrotoxicity Eur Heart J 25 2004 206 211 (Pubitemid 38235156)
9. A.V. Kshirsagar, C. Poole, and A. Mottl N-acetylcysteine for the prevention of radiocontrast induced nephropathy: a meta-analysis of prospective controlled trials J Am Soc Nephrol 15 2004 761 769 (Pubitemid 38294807)
10. N. Pannu, B. Manns, H. Lee, and M. Tonelli Systematic review of the impact of N-acetylcysteine on contrast nephropathy Kidney Int 65 2004 1366 1374 (Pubitemid 38406975)
11. S.M. Bagshaw, and W.A. Ghali Acetylcysteine for prevention of contrast-induced nephropathy after intravascular angiography: a systematic review and meta-analysis BMC Med 2 2004 38 [22]
12. A.M. Kelly, B. Dwamena, P. Cronin, S.J. Bernstein, and R.C. Carlos Meta-analysis: effectiveness of drugs for preventing contrast-induced nephropathy Ann Intern Med 148 2008 284 294 (Pubitemid 351665489)
13. C.S. Baker, A. Wragg, and S. Kumar A rapid protocol for the prevention of contrast-induced renal dysfunction: the RAPPID study J Am Coll Cardiol 41 2003 2114 2118 (Pubitemid 36724254)
14. J.G. Webb, G.E. Pate, and K.H. Humphries A randomized controlled trial of intravenous N-acetylcysteine for the prevention of contrast-induced nephropathy after cardiac catheterization: lack of effect Am Heart J 148 2004 422 429 (Pubitemid 39265114)
15. S.T. Rashid, M. Salman, and F. Myint Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine J Vasc Surg 40 2004 1136 1141 (Pubitemid 40037281)
16. N. Carbonell, M. Blasco, and R. Sanjuán Intravenous N-acetylcysteine for preventing contrast-induced nephropathy: a randomised trial Int J Cardiol 115 2007 57 62 (Pubitemid 44855192)
17. D.W. Cockcroft, and M.H. Gault Prediction of creatinine clearance from serum creatinine Nephron 16 1976 31 41
18. J. Kay, W.H. Chow, and T.M. Chan Acetylcysteine for prevention of acute deterioration of renal function following elective coronary angiography and intervention: a randomized controlled trial JAMA 289 2003 553 558 (Pubitemid 37428626)
19. J.D. Durham, C. Caputo, and J. Dokko A randomized controlled trial of N-acetylcysteine to prevent contrast nephropathy in cardiac angiography Kidney Int 62 2002 2202 2207 (Pubitemid 35366176)
20. C. Briguori, F. Manganelli, and P. Scarpato Acetylcysteine and contrast agent-associated nephrotoxicity J Am Coll Cardiol 40 2002 298 303 (Pubitemid 34756291)
21. C. Sandhu, A.M. Belli, and D.B. Oliveira The role of N-acetylcysteine in the prevention of contrast-induced nephrotoxicity Cardiovasc Intervent Radiol 29 2006 344 347
22. F. Boccalandro, M. Amhad, and R.W. Smalling Oral acetylcysteine does not protect renal function from moderate to high doses of intravenous radiographic contrast Catheter Cardiovasc Interv 58 2003 336 341 (Pubitemid 36259222)
23. I. Goldenberg, M. Shechter, and S. Matetzky Oral acetylcysteine as an adjunct to saline hydration for the prevention of contrast-induced nephropathy following coronary angiography: a randomized controlled trial and review of the current literature Eur Heart J 25 2004 212 218 (Pubitemid 38235157)
24. J.W. Fung, C.C. Szeto, and W.W. Chan Effect of N-acetylcysteine for prevention of contrast nephropathy in patients with moderate to severe renal insufficiency: a randomized trial Am J Kidney Dis 43 2004 801 808 (Pubitemid 38529617)
25. M. Agawal, A. Wodlinger, and C. Huggins Effect of N-acetylcysteine on serum creatinine concentration in patients with chronic renal insufficiency who are undergoing coronary angiography Heart Drug 4 2004 87 91 (Pubitemid 38608299)
26. S.E. Miner, V. Dzavik, and P. NguyeN-Ho N-acetylcysteine reduces contrast-associated nephropathy but not clinical events during long-term follow-up Am Heart J 148 2004 690 695 (Pubitemid 39349390)
27. S.J. Shalansky, T. Vu, and G.E. Pate N-acetylcysteine for prevention of radiographic contrast material-induced nephropathy: is the intravenous route best? Pharmacotherapy 25 2005 1095 1103 (Pubitemid 41099444)
28. P.A. Poletti, P. Saudan, and A. Platon I.v. N-acetylcysteine and emergency CT: use of serum creatinine and cystatin C as markers of radiocontrast nephrotoxicity AJR Am J Roentgenol 189 2007 687 692 (Pubitemid 47328553)
29. S. Fishbane, J.H. Durham, and K. Marzo Nacetylcysteine in the prevention of radiocontrast-induced nephropathy J Am Soc Nephrol 15 2004 251 260
30. H.S. Thomsen Guidelines for contrast media from the European Society of Urogenital Radiology AJR Am J Roentgenol 181 2003 1463 1471 (Pubitemid 37466517)
31. American College of Radiology. Manual on contrast media, version 5.0. (Accessed December 30, 2005, at http://www.acr.org/s-acr/sec.asp?CID= 2131&DID=16687).
32. S.D. Weisbord, and P.M. Palevsky Prevention of contrast-induced nephropathy with volume expansion Clin J Am Soc Nephrol 3 2008 273 280
33. H.S. Trivedi, H. Moore, and S. Nasr A randomized prospective trial to assess the role of saline hydration on the development of contrast nephrotoxicity Nephron Clin Pract 93 2003 29 34
34. C. Mueller, G. Buerkle, and H.J. Buettner Prevention of contrast media-associated nephropathy: randomized comparison of 2 hydration regimens in 1620 patients undergoing coronary angioplasty Arch Intern Med 162 2002 329 336 (Pubitemid 34127411)
35. R.A. Krasuski, B.M. Beard, and J.D. Geoghagan Optimal timing of hydration to erase contrast-associated nephropathy: the OTHER CAN study J Invasive Cardiol 15 2003 699 702 (Pubitemid 37549287)
36. B.D. Bader, E.D. Berger, and M.B. Heede What is the best hydration regimen to prevent contrast media-induced nephrotoxicity? Clin Nephrol 62 2004 1 7 (Pubitemid 38979102)
37. G.J. Merten, W.P. Burgess, and L.V. Gray Prevention of contrastinduced nephropathy with sodium bicarbonate: a randomized controlled trial JAMA 291 2004 2328 2334 (Pubitemid 38656299)
38. I. Goldenberg, and S. Matetzky Nephropathy induced by contrast media: pathogenesis, risk factors and preventive strategies CMAJ 172 2005 1461 1471 (Pubitemid 40803495)
39. E. Cholongitas, V. Shusang, and L. Marelli Review article: renal function assessment in cirrhosis-difficulties and alternative measurements Aliment Pharmacol Ther 26 2007 969 978 (Pubitemid 47421959)
40. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150